Tier 1
Essential Medicines Manufacturing
Indicative CAPEX
$15M – $80M
Market position
20–40%
import substitution opportunity
Tanzania imports more than 80% of its medicines, and essential generics sit at the top of the national procurement list. Manufacturing essential medicines inside MPMED-SEZ places your plant next to a guaranteed buyer: MSD procures USD 491M of health commodities every year and applies a 15% price preference to qualifying local manufacturers. Tier 1 plants are the fastest route to recurring, framework-contract revenue.
Why this tier
- MSD framework contracts with 15% local price preference
- WHO-PQ and GMP support through the TMDA 60-day fast-track
- 20–40% import substitution headroom in national demand
Next steps
Review the regulatory pathway · See the incentive package
Submit EOI for this tier